11111

Programme

11111

academic

Programme

  • Guatemala 12th November 2025

Opening

13:30

Dr. Jarbas Barbosa, Director, Pan American Health Organization (PAHO)

Dr. Joaquín Barnoya, Minister of Health, Guatemala

Dr. Nuria Chávez Salazar, President, Guatemalan Association of Infectious Diseases (AGEI)

Dr. Carlos Tapia, President, Guatemalan Association of Pulmonology and Thoracic Surgery (AGNCT)

Dr. Julio Tejada, President, College of Physicians and Surgeons of Guatemala

Advancements in Pneumonia Diagnosis: Tools, Technologies, and Global Access

13:50 Major gaps in childhood pneumonia research priorities

Dr. Carina King, Karolinska Institute, Department for Global Public Health, Solna, Sweden

14:10 Assessing Devices for Community Pneumonia Diagnosis

Dr. Kevin Baker, International Consultant

Optimizing Oxygen Therapy: Addressing Global Gaps in Access and Delivery

14:30 The Lancet Global Health Oxygen Commission

Dr. Zoë Mullan, Editor-in-Chief, The Lancet Global Health

14:50 Oxygen Inequities in Latin America: Bridging the Gap for Better Health

Dr. Karen Czischke, Department of Pulmonary Medicine, Clínica Alemana de Santiago, Universidad del Desarrollo, Santiago, Chile

Antibiotic Resistance in Pneumonia: Global Challenges and Effective Strategies

15:10 Antimicrobial Resistance and the Impact on Latin America

Dr. Mohsen Naghavi, Institute for Health Metrics and Evaluation (IHME)

15:30 The Role of Vaccines in the Fight Against Antimicrobial Resistance

Prof. Noni Macdonald, Division of Infectious Diseases, Department of Paediatrics, Dalhousie University and IWK Health Centre, Halifax, NS

Breaking Barriers: How Pneumonia Vaccines Can Save Lives Worldwide

15:50 Fractional pneumococcal vaccine

Prof. Fiona Russell, Department of Paediatrics, The University of Melbourne, Melbourne, VIC 3052, Australia; Infection and Immunity, Murdoch Children's Research Institute, Melbourne, VIC, Australia

16:10 Advancing RSV Prevention: Effective Vaccines and Antibodies for Protecting Infants Globally

Prof. Heather Zar, Department of Pediatrics and Child Health, Red Cross War Memorial Children's Hospital and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, South Africa

The Global Threat of Respiratory Pandemics: Understanding the Risks of Influenza H5N1 and Emerging Viruses

16:30 Influenza A (H5N1): Understanding the Threat and Preparing for the Future

Prof. Timothy Uyeki, Influenza Division, CDC, Atlanta, USA

16:50 Double Threat: The Risk of Pneumonia from Respiratory Viruses and Secondary Bacterial Infections

Prof. Keith Klugman, Director of Pneumonia and Pandemic Preparedness, Gates Foundation

Collaborative Efforts in Combating Pneumonia: International Partnerships and Best Practices

17:10

Professor Francisco Arancibia, Past-President, The Latin American Thoracic Association (ALAT)

Professor Silke Ryan, President, European Respiratory Society (ERS)

Professor Irina Petrache, President, The American Thoracic Society (ATS)

Mr. Dimitris Kontopidis, President, European Lung Foundation (ELF)

Professor Refiloe Masekela, President, Pan African Thoracic Society (PATS)

Dr. Edgar Amilcar Contreras, Representative of the Guatemalan Association of Internal Medicine (AMIG)

11111

ABOUT CONFERENCE

Schedule Plan

  • Day 01 01 Nov 2019
  • Day 02 02 Nov 2019
  • Day 03 03 Nov 2019
  • Day 04 04 Nov 2019
9.00 AM - 10.00 PM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
10.00 AM - 11.00 AM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
11.00 AM - 12.00 AM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
12.00 AM - 01.00 PM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
9.00 AM - 10.00 PM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
10.00 AM - 11.00 AM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
11.00 AM - 12.00 AM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
12.00 AM - 01.00 PM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
9.00 AM - 10.00 PM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
10.00 AM - 11.00 AM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
11.00 AM - 12.00 AM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
12.00 AM - 01.00 PM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
9.00 AM - 10.00 PM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
10.00 AM - 11.00 AM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
11.00 AM - 12.00 AM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...
12.00 AM - 01.00 PM
Ashli Scroggy
Founder & CEO

Modern Marketing Summit Sydney 2018

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea...

11111

Dear Colleagues & Friends,

As Chairpersons of the 4th Global Conference for World Pneumonia Day 2024, it gives us great pleasure to invite you to join our event, which is part of the Worldwide Pneumonia Awareness Campaign-Pneumolight, with the support of the Philippine College of Physicians (PCP) in Manila, to be held on 9 November 2024.

Despite the global impact of the COVID-19 pandemic, pneumonia remains a neglected disease. Sadly, the 2021 Global Burden of Disease report showed that 2.1 million people died of pneumonia in that year; children under five years and adults over 70 continued to be the most vulnerable populations, with more than 500,000 and 1 million pneumonia-related deaths respectively. Another important problem is the impact of antimicrobial resistance (AMR); according to the 2019 GBD report, 1.27 million deaths were attributable to bacterial AMR in that year, and one in five deaths caused by AMR occurred in children under five years old. The 2019 GBD report identified Streptococcus pneumoniae as the most frequent pathogen causing pneumonia,
contributing to 16% of the deaths attributable to AMR.

Although great progress continues to be made, the worldwide burden of pneumonia remains huge. We need everyone to know about the disease and its impact on our health, and above all, we need to show that it can be prevented. Pneumonia must be recognized as a major global health problem. Until this recognition comes, we will continue our attempts to educate and prevent, because we know that education is prevention and prevention saves lives.

Working together, we can move the world because we know that if we fight, we can win!!!!

Yours sincerely,

Catia Cilloniz
Guinevere Dy-Agra
Rodolfo S. Pagcatipunan Jr

This will close in 0 seconds

This will close in 0 seconds

This will close in 0 seconds

Louis Bont, MD, PhD


Louis Bont, MD, PhD, is a Pediatric Infectiologist-Immunologist and the head of the Pediatric Department at the University Medical Center Utrecht, The Netherlands. He is the founding chairman of ReSViNET, an international respiratory syncytial virus (RSV) research consortium. His specific research interests include RSV pathogenesis and the burden of disease.

Dr. Bont's work focuses on unraveling the role of neutrophils, RSV-related mortality, and long-term airway disease following RSV infection. He is the lead investigator of the INFORM study, a large prospective global clinical virology study that aims to uncover the molecular epidemiology of RSV in over 2000 children. He also leads the RSV GOLD mortality registry, funded by the Bill and Melinda Gates Foundation.

His group collaborates with the World Health Organization on RSV surveillance and vaccine development. Dr. Bont’s research emphasizes clinical and translational mechanisms of disease and the identification of intervention targets for RSV bronchiolitis. He has been the lead author of over 300 publications in peer-reviewed medical journals.

Additionally, he founded the Training of Upcoming Leaders in Pediatric Science (TULIPS), a career training network for clinician scientists in the field of Child Health.

This will close in 0 seconds

This will close in 0 seconds